𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus

✍ Scribed by A. Clancy; B. Crowley; H. Niesters; C. Herra


Publisher
Springer
Year
2008
Tongue
English
Weight
112 KB
Volume
27
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparison of real-time fluorescent RT-P
✍ Chenyan Zhao; Zhuo Li; Baoshan Yan; Tim J. Harrison; Xinhui Guo; Feng Zhang; Jim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract To compare the specificity and sensitivity of a real‐time fluorescent RT‐PCR assay with conventional RT‐PCR, sera from 110 healthy blood donors, 120 patients with a clinical diagnosis of chronic hepatitis B, and 416 patients with non‐A‐C acute hepatitis, as well as serial dilutions of H

Development and evaluation of a fluoroge
✍ Irene L. Tan; Mark Pierre S. Dimamay; Corazon C. Buerano; Jhoe Anthony R. Alfon; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

## Abstract A dengue‐3‐specific real‐time reverse transcriptase‐polymerase chain reaction (RT‐PCR) was developed using the novel __L__ight __U__pon e__X__tension (LUX™) fluorogenic technology. A labeled forward primer and a standard reverse primer that target a conserved region within the non‐struc

Performance of two Real-Time RT-PCR assa
✍ Abeer Elkady; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Masaya Sugiyama 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

## Abstract Accuracy for monitoring of the concentration of hepatitis C virus (HCV) RNA represents a major challenge throughout the management of patients with chronic hepatitis C. To investigate the genotype‐independent efficiency and the accuracy of two real‐time detection reverse transcription‐p

Prediction of the efficacy of antiviral
✍ Ei Kinai; Hideji Hanabusa; Shingo Kato 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract The efficacy of interferon therapy for hepatitis C virus (HCV) infection improved remarkably. However, virologic relapse occurs in a substantial proportion of patients with virologic response (defined as an HCV RNA level below 50 IU/ml at the end‐of‐treatment). A highly sensitive RT‐nes